Actively Recruiting
A Pilot Study of The CKM JumpStart Tool to Promote Conservative Kidney Management Discussions in Older Adults with Advanced Chronic Kidney Disease
Led by University of Washington · Updated on 2024-08-09
76
Participants Needed
2
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the use of a new communication tool called the CKM JumpStart Tool to encourage discussions about conservative kidney management CKM between older patients with advanced chronic kidney disease CKD and their healthcare providers. This randomized pilot study involves patients aged 75 years and older, aiming to test if the tool is feasible and acceptable compared to usual care. The study is sponsored by the University of Washington and includes patients from two healthcare systems. The CKM JumpStart Tool is a one-page handout tailored to each patient based on their values related to longevity or comfort. Study staff generate this tool before the patients clinic visit and share it with both patient and provider to facilitate values-based conversations about CKM. Participants are randomly assigned either to receive this intervention or to continue with usual care without the tool. The study collects data at enrollment, within two weeks after the clinic visit, and about three months later. Participants will provide information through surveys and interviews at three time points at enrollment, shortly after their next clinic visit, and three months later. Researchers will assess how often CKM discussions occur between patients and providers, whether providers document these discussions, and how acceptable and feasible the tool is based on participant retention and feedback. The study also includes qualitative interviews with patients and nephrologists to understand their experiences using the tool.
CONDITIONS
Brief Title
A Pilot Study of The CKM JumpStart Tool
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 675 years
- Diagnosed with advanced chronic kidney disease defined by at least two outpatient eGFR measures less than 25 ml/min/1.73m2 separated by more than 90 days in the prior year and at least one eGFR measure less than 20
- English-speaking
- Receiving care from a provider at University of Washington Medicine or VA Puget Sound
- Willing to discuss values and treatment options for kidney disease with their healthcare provider
You will not qualify if you...
- Unable to complete the informed consent process
- Currently receiving maintenance dialysis
- None for healthcare providers participating in the study
Research Team
O
Olivia Gaughran, MA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here